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Background and aim: Anxiety disorders are one of the most common psychiatric disorders worldwide. Common
anti-anxiety medications are associated with several side effects. Caffeic acid (CA) is a phenolic compound with
several pharmacological effects. The aim of this study was to investigate the anxiolytic-like effect of CA in
maternally separated (MS) mice focusing on the possible involvement of the NMDA receptor.
Materials and methods: In this study, we used the MS paradigm (as a valid animal model of anxiety) in male mice
and examined their anxiety-like behavior in postnatal day (PND) 45. The animals were divided into 12 experi-
mental groups. Mice treated with CA alone and in combination with the NMDA receptor agonist/antagonist and
then using open field (OFT) and elevated plus maze (EPM) anxiety-like behavior was assessed. Finally, the
expression of NMDA receptor subtypes was assessed in the hippocampus using RT- PCR.
Results: Finding showed that CA exerted anxiolytic –like effects in the OFT and EPM tests. We showed that
administration of effective dose of NMDA significantly reversed the anxiolytic-like effect of effective dose of CA
and co-administration of ketamine (a NMDA receptor antagonist) significantly potentiated the effect of sub-
effective dose of CA. Furthermore, ketamine enhanced the CA-reducing effect on NMDA receptors in the MS mice.
Conclusion: Our finding demonstrated that, probably at least, NMDA receptors are involved in the anxiety-like
properties of CA in MS mice.1. Introduction
Anxiety is an unpleasant and elusive feeling with inquietude behavior
[1]. It is estimated that about one-eighth of the world's population suffers
from anxiety [2]. Repeated stress exposure during the early life is could
lead to adverse behavioral effects in the adulthood [3]. Maternal sepa-
ration (MS) is defined as the lack of care or short-term care during the
early stages of childhood development. This paradigm can negatively
affect brain development, cognition, and social behavior in adulthood
[4]. In this regard, the literature shows that children who are exposed to
the MS paradigm are prone to anxiety, depression and memory loss [5, 6,
7]. A substantial body of evidence suggests that early life stress, such as
MS, causes long-term behavioral disorders such as anxiety [5, 8].
N-methyl D-aspartate (NMDA) receptor is one of the sites of action for
glutamate [9]. The NMDA receptor plays an important role in the
development of mood and cognition [10, 11]. Activation of NMDA re-
ceptors has been shown to be associated with anxiety-like behavior [12].khoyi.h@skums.ac.ir (H. Amini-K
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NMDA receptor antagonists reduced the anxiety behavior in both clinical
and experimental studies [12, 13].
The hippocampus is an important structure in the brain that plays an
important role in shaping behavior [14]. Previous studies have shown
that activation of NMDA receptors in the hippocampus leads to
anxiety-like behavior in rodents [12, 13]. Therefore, the hippocampus
and its NMDA receptors can be considered a major target for the devel-
opment of anti-anxiety drugs.
Although commonly used chemical drugs are highly effective how-
ever, they also have side effects [15]. Therefore, researches are needed to
findmore effective drugs with fewer side effects. Traditionally, medicinal
plants and their active ingredients have attracted the attention of re-
searchers in the treatment of various disorders [16]. Caffeic Acid (CA), 3,
4 hydroxycinnamic acid, is a polyphenolic compound that is widely
found in fruits and plants [17]. Previous studies have introduced various
pharmacological properties for CA including antitumor [18], analgesichoei).
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Table 1. Sequences of primers.
name sequence
Nr2a-F CTCAGCATTGTCACCTTGGA
Nr2a-R GCAGCACTTCTTCACATTCAT
Nr2b-F CTACTGCTGGCTGCTGGTGA
Nr2b-R GACTGGAGAATGGAGACGGCTA
H2afz-F TCATCGACACCTGAAATCTAGGA
H2afz-R AGGGGTGATACGCTTTACCTTTA
Z. Lorigooini et al. Heliyon xxx (xxxx) xxx[19], anti-Alzheimer's [20], and anti-inflammatory effects [21]. It has
been shown that CA has neuroprotective effect in experimental neuro-
logic disorders [22]. It has been determined that CA exerted antide-
pressant- and anxiolytic-like effects in rodents [23, 24]. However, the
exact mechanisms are involved in the anxiolytic-like effect of CA has not
been established.
Considering that 1) MS causes anxiety-like behavior, 2) NMDA re-
ceptors are involved in the pathophysiology of anxiety, 3) CA have
exerted various neuroprotective effect, in this study we aimed to evalu-
ated the anxiolytic-like effect of CA in mouse model of MS stress focusing
possible contribution of NMDA receptors.
2. Material and methods
2.1. Ethics
The present study was conducted in accordance with the guide for the
care and use of laboratory animals as adopted by the committee on the
care and use of laboratory animals of Shahrekord University of medical
science with ethical code: IR.SKUMS.REC.1396. 101.
2.2. Animals
In this study (supported by a research grant (NO: 1396-08-75-3439)
from Shahrekord University of Medical Sciences, Shahrekord, Iran), 96
male NMRI mice were used. To induce anxiety-like behavior, maternal
separation (MS) stress paradigm was used [25, 26]. To perform this
model, mice were separated from their mothers for 3 h daily on their
third day of birth and then returned to their mother's cage. This paradigm
continues until the 14th day after birth. The mice were then kept in cages
in groups of 6 from day 14 to day 45 after birth. Tests are performed
between 45 and 47 days after birth. The tested groups are as follows:
1. Control group (non-stressed animals received normal saline), 2.
Stress group (MS mice received normal saline.), Groups 3–5 non-stress
animals received CA at doses of 15, 30 and 45 mg/kg, groups 6–8 MS
mice received CA at doses of 15, 30 and 45 mg/kg, 9. MS mice received
NMDA agonist (7.5 mg/kg, i.p.), 10. MS mice received NMDA antagonist
(ketamine) (1 mg/kg, i.p.), 11. MSmice received sub-effective dose of CA
plus ketamine (1 mg/kg), 12. MS mice received an effective dose of CA
plus effective dose of NMDA agonist (7.5 mg/kg).
Caffeic acid was injected as single dose via intraperitoneal route 30
min before behavioral tests. NMDA receptor antagonist or agonist is
administered as single dose via intraperitoneal route 60 min before
behavioral assessments. Doses and time of drugs administration was
chosen based on previous studies as well as our pilot study [27, 28, 29].
All experimental groups involved 8 mice for behavioral assessments and
6 mice for RT-PCR evaluations and we tried to minimize the use of ani-
mals and to improve their well-being.
2.3. Open field test (OFT)
The OFT was used as a trial to evaluate the anxiety-like behavior and
motor function in rodents. OFT apparatus is a Plexiglas box (40 50 60
cm). Mice were placed individually on the center of the box, and each
animal's movements monitored and recorded during 5 min. Time spent in
the central zone as a scale for assessment of anxiety-like behavior was
recorded [30]. Increase in time spent in central zone of the OFT indi-
cating the anxiolytic-like behavior. Furthermore, the distance moved
(horizontal activity, number of crossing by 4 foots from each square) was
recorded. After each experiment, the apparatus was cleaned using
ethanol 70%.
2.4. Elevated plus maze (EPM)
The EPM is an appropriate tool to assess the anxiety-like behavior in
rodents. The EPM apparatus is a black opaque Plexiglas consists of two2
open arms and two closed arms located at a height of 50 cm above the
ground. Animals were individually placed in the center of the EPM facing
to closed arms. The total time spent in the open and close arms, and
number of entries into the open and close arms as well as total entries was
recorded over a period of 5 min [31].2.5. Real-time PCR
At the end of the experiment, mice were sacrificed under anesthesia
using diethyl ether, and the hippocampus was isolated and the gene
expression of NMDA receptor subunits (NR2a and NR2b) was assessed by
Real-time PCR [32]. At first total RNA using TRIzol reagent (Invitrogen)
was extracted. Alterations in mRNA levels of genes were determined
using qRT-PCR after reverse transcription of 1 μg of RNA from each
sample using PrimeScript RT reagent kit (Takara Bio, Inc., Otsu, Japan).
qRT-PCR was done on a light cycler device (Roche Diagnostics, Man-
nheim, Germany) using SYBR Premix Ex Taq technology (Takara Bio).
Thermal cycling conditions were including an initial activation step for
30 s at 95 C afterwards 45 cycles as well as a denaturation step for 5 s at
95 C and a combined annealing/extension step for 20 s at 60 C. Melting
curve analysis was performed to certify whether all primers yielded a
single PCR product. The reaction for each gene is in triplicate and is
repeated twice. The favorite primers were designed using Primer 3
software version 0.4.0 (Table 1). The H2afz gene was considered as
normalizer [33]. The rate of change in the expression of the target genes
was compared to the control group. Finally, the data obtained from
Real-time PCR are presents as fold change expression.2.6. Statistical analysis
Statistical analysis was performed using SPSS software and the results
were presented as Mean  SEM. One-way ANOVA and Tukey's post hoc
tests were used for analysis. P values < 0.05 were considered to be sta-
tistically significant.
3. Results
3.1. Caffeic acid increases the time spent in central zone as well as
decreases distance moved in the OFT
One way ANOVA analysis showed that there is significant difference
among the experimental groups (F (11, 85)¼ 18.22 (P< 0.001)). Results
showed that the time spent in the center of OFT was significantly less in
the MS group in compared with the control group (Figure 1, P < 0.05).
Time spent in center of the OFT in the MSmice received CA at doses of 30
and 45 mg/kg was significantly longer than saline-received MSmice (P>
0.01). Furthermore, administration of NMDA (150 mg/kg) to MS mice
significantly decreased the time spent in central zone in compared with
saline-received counterpart (P < 0.05). Our findings demonstrated that
co-administration of sub-effective dose of CA (15 mg/kg) plus Ket (0.25
mg/kg) significantly increased the time spent in central zone in com-
parison with group received sub-effective dose of CA (15 mg/kg) (P <
0.05). In addition, co-injection of NMDA (150 mg/kg) plus effective dose
of CA (45 mg/kg) to the MS mice decreased the time spent in the central
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Figure 1. Comparison of time spent in the central zone of OFT in experimental
groups. Data are expressed as mean  SEM and was analysis using one-way
ANOVA following Tukey post-hoc test. *P < 0.05 in compared to the saline-
treated control group, & P < 0.05 and && P < 0.01compared with the saline
–treated MS mice, #P < 0.05 compared with CA 15 mg/kg-received MS mice
and $ P < 0.05 compared with CA 45 mg/kg-received MS mice. CA: caffeic acid,
Ket: ketamine and MS: maternal separation.
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Figure 3. Comparison of time spent in the EPM open arms in experimental
groups. Data are expressed as mean  SEM and was analysis using one-way
ANOVA following Tukey's post-hoc test. ***P < 0.001 in compared to the
saline-treated control group, & P < 0.05 and && P < 0.01compared with the
saline –treated MS mice, #P < 0.05 compared with CA 15 mg/kg-received MS
mice. CA: caffeic acid, Ket: ketamine and MS: maternal separation.
Z. Lorigooini et al. Heliyon xxx (xxxx) xxxzone of OFT in a significant manner in compared to the group received
effective dose of CA (45 mg/kg) alone (P < 0.05).
One way ANOVA analysis showed that there is significant difference
among the experimental groups (F (11, 85) ¼ 10.13 (P < 0.01)). Results
showed that the horizontal activity was significantly increased in the MS
group in compared with the control group (Figure 2, P < 0.05). The
horizontal activity in the MS mice received CA at doses of 30 and 45 mg/
kg was significantly decreased in compared with the saline-received MS
mice (P > 0.05).3.2. Caffeic acid increases the time entries to the open arms as well as
decreased the time entries to the open arms of the EPM
One way ANOVA analysis showed that there is significant difference
among the experimental groups in case of open arms entries in the EPM
(F (11, 85) ¼ 12.38 (P < 0.01)). Results showed that, the time entry in
EPM open arms was significantly lower in the MS group than the control
group (Figure 3, P < 0.001). The time spent in EPM open arms in the MS
mice received CA at doses of 30 and 45 mg/kg was significantly longerSa
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Figure 2. Comparison of the horizontal activities in the OFT in experimental
groups. Data are expressed as mean  SEM and was analysis using one-way
ANOVA following Tukey post-hoc test. *P < 0.05 in compared to the saline-
treated control group and & P < 0.05 compared with the saline –treated MS
mice. CA: caffeic acid, Ket: ketamine and MS: maternal separation.
3
than saline-received MS mice (P > 0.01). Furthermore, administration of
NMDA (150 mg/kg) to MS mice significantly decreased the time spent in
EPM open arms in compared to the saline-received counterpart (P <
0.05). Our findings demonstrated that co-administration of sub-effective
dose of CA (15 mg/kg) plus Ket (0.25 mg/kg) significantly increased the
time spent in the open arms of EPM in comparison with the group
received sub-effective dose of CA (15 mg/kg) alone (P < 0.05).
One way ANOVA analysis showed that there is significant difference
among the experimental groups in case of close arms entries in the EPM
(F (11, 85) ¼ 19.25 (P < 0.001)). Results showed that, the time entry in
EPM close arms was significantly longer in the MS group than the control
group (Figure 4, P < 0.001). The time spent in EPM close arms in the MS
mice received CA at doses of 30 and 45 mg/kg was significantly
decreased in compared with the saline-received MS mice (P > 0.01).
Furthermore, administration of NMDA (150 mg/kg) to MS mice signifi-
cantly increased the time spent in EPM close arms in compared to the
saline-received counterpart (P < 0.05). Our findings demonstrated that
co-administration of sub-effective dose of CA (15 mg/kg) plus Ket (0.25
mg/kg) significantly decreased the time spent in the close arms of EPM in
comparison with the group received sub-effective dose of CA (15 mg/kg)
alone (P < 0.05).Sa
lin
e 
Sa
lin
e 
CA
 15
CA
 30
CA
 45
 
CA
 15
CA
 30
CA
 45
NM
DA
 15
0
ke
t 0
.25
CA
15
+K
et 
0.2
5
CA
 45
NM
DA
15
0
0
100
200
300
cl
os
e 
ar
m
 ti
m
e
Control
MS***
&&
&&
&
#
Figure 4. Comparison of time spent in the EPM close arms in experimental
groups. Data are expressed as mean  SEM and was analysis using one-way
ANOVA following Tukey's post-hoc test. ***P < 0.001 in compared to the
saline-treated control group, && P < 0.01compared with the saline –treated MS
mice, #P < 0.05 compared with CA 15 mg/kg-received MS mice. CA: caffeic
acid, Ket: ketamine and MS: maternal separation.
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Figure 6. Comparison of the entries frequency in the EPM close arms in
experimental groups. Data are expressed as mean  SEM and was analysis using
one-way ANOVA following Tukey's post-hoc test. ***P < 0.001 in compared to
the saline-treated control group, & P < 0.05 and &&& P < 0.001 compared with
the saline –treated MS mice, ##P < 0.01 compared with CA 15 mg/kg-received
MS mice and $ P < 0.05 compared with CA 45 mg/kg-received MS mice. CA:
caffeic acid, Ket: ketamine and MS: maternal separation.
Z. Lorigooini et al. Heliyon xxx (xxxx) xxx3.3. Caffeic acid increases the number of entries to the EPM open arms
One way ANOVA analysis showed that there is significant difference
among the experimental groups in case of number of entries to the EPM
open arms (F (11, 85)¼ 11.41 (P< 0.01)). As Figure 5 shows, the entries
frequency of EPM open arms in the MS group was significantly lower
than the control group (P < 0.05). The entries frequency of EPM open
arms in the MS mice received CA at dose of 45 mg/kg was significantly
higher than saline-received MS mice (P > 0.01). Furthermore, adminis-
tration of NMDA (150 mg/kg) to MS mice significantly decreased the
entries frequency of EPM open arms in compared with saline-received
counterpart (P < 0.05). Our findings demonstrated that co-
administration of sub-effective dose of CA (15 mg/kg) plus Ket (0.25
mg/kg) significantly increased the frequency of EPM open arm entry in
comparison with group received sub-effective dose of CA (15 mg/kg)
alone (P < 0.05). In addition, co-injection of NMDA (150 mg/kg) plus
effective dose of CA (45 mg/kg) to the MS mice decreased the entries
frequency of EPM open arms in a significant manner in compared to the
MS group received effective dose of CA (45 mg/kg) alone (P < 0.05).
One way ANOVA analysis showed that there is significant difference
among the experimental groups in case of number of entries to the EPM
close arms (F (11, 85) ¼ 25.36 (P < 0.001)). As Figure 6 shows, the
entries to the EPM close arms was significantly increased in the MS group
in comparison with the control group (P < 0.001). The entries frequency
of EPM close arms in the MS mice received CA at doses of 30 and 45 mg/
kg was significantly lower than saline-received MS mice (P > 0.05 and P
> 0.001, respectively). Furthermore, administration of ketamine (0.25
mg/kg) to MS mice significantly decreased the entries frequency of EPM
close arms in compared with saline-received counterpart (P < 0.05). Our
findings demonstrated that co-administration of sub-effective dose of CA
(15 mg/kg) plus Ket (0.25 mg/kg) significantly decreased the frequency
of EPM close arm entry in comparison with group received sub-effective
dose of CA (15 mg/kg) alone (P < 0.01). In addition, co-injection of
NMDA (150 mg/kg) plus effective dose of CA (45 mg/kg) to the MS mice
increased the entries frequency of EPM close arms in a significant manner
in compared to the MS group received effective dose of CA (45 mg/kg)
alone (P < 0.05).
One way ANOVA analysis showed that there is no significant differ-
ence among the experimental groups in case of total entries in the EPM (F
(11, 85) ¼ 6.13 (P > 0.05)). As Figure 7 shows, neither condition
(maternal separation) nor treatments did not change the total entries to
the EPM amongst experimental groups.Sa
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Figure 5. Comparison of the entries frequency in the EPM open arms in
experimental groups. Data are expressed as mean  SEM and was analysis using
one-way ANOVA following Tukey's post-hoc test. *P < 0.05 in compared to the
saline-treated control group, & P < 0.05 compared with the saline –treated MS
mice, #P < 0.05 compared with CA 15 mg/kg-received MS mice and $ P < 0.05
compared with CA 45 mg/kg-received MS mice. CA: caffeic acid, Ket: ketamine
and MS: maternal separation.
4
3.4. Caffeic acid modulates the expression of NR2a and NR2b subunits of
NMDA receptors in the hippocampus
One way ANOVA analysis showed that there is significant difference
among the experimental groups in case of expression of the NR2a (F (5,
30)¼ 9.58 (P< 0.05)) and NR2b (F (5, 30)¼ 14.11 (P< 0.01)). Findings
showed that expression of NR2a (Figure 8) and NR2b (Figure 9) subunits
of NMDA receptors was significantly increased in the MS group in com-
parison with the control mice (P < 0.05). Expression of NR2b subunit of
NMDA receptors in the MS mice received CA at dose of 45 mg/kg was
significantly lower than saline-received MS mice (P < 0.05). We
demonstrated that co-administration of sub-effective dose of CA (15 mg/
kg) plus Ket (0.25 mg/kg) significantly decreased the expression of NR2b
subunit of NMDA receptors in comparison with group received sub-
effective dose of CA (15 mg/kg) alone (P < 0.05).
4. Discussion
In this study, we found that the separation of infants from mothers
causes anxiety-like behaviors in adulthood. MS mice had a significantSa
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Figure 7. Comparison of the total entries to the EPM arms in experimental
groups. Data are expressed as mean  SEM and was analysis using one-way
ANOVA following Tukey's post-hoc test. CA: caffeic acid, Ket: ketamine and
MS: maternal separation.
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Figure 8. Comparison of the expression of NR2a subunit of NMDA receptors in
experimental groups. Data are expressed as mean  SEM and was analysis using
one-way ANOVA following Tukey's post-hoc test. *P < 0.05 in compared to the
saline-treated control group. CA: caffeic acid, MS: maternal separation.
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Figure 9. Comparison of the expression of NR2b subunit of NMDA receptors in
experimental groups. Data are expressed as mean  SEM and was analysis using
one-way ANOVA following Tukey's post-hoc test. *P < 0.05 in compared to the
saline-treated control group, & P < 0.05 compared with the saline –treated MS
mice, #P < 0.05 compared with CA 15 mg/kg-received MS mice. CA: caffeic
acid, MS: maternal separation.
Z. Lorigooini et al. Heliyon xxx (xxxx) xxxreduction in the frequency of entries and time spent on open arms in the
EPM, and also spent less time in the central zone of the OFT in com-
parison with the control mice. The gene expression of NMDA receptors
significantly increased in the hippocampus of MS mice. We showed that
administration of CA significantly reversed the negative effect of MS on
behavior as well as reduced the expression of NMDA receptor subunits
(NR2b) in the hippocampus. Surprisingly, we found that the beneficial
effect of CA as an anxiolytic agent (at least in part) is mediated by NMDA
receptors. In this concept, co-administration of NMDA receptor antago-
nist (ketamine) potentiated the effect of sub-effective dose of CA. In
addition, administration of NMDA plus effective dose of CA significantly
mitigated the anxiolytic effect of CA.5
Anxiety is one of the most common psychiatric diseases [34]. Expe-
riencing adverse events in early periods of life harmfully affects devel-
opment of the brain and behavior and also, is regarded as a risk factor for
susceptibility to psychiatric disorders. It has been well established that
early life stress as maternal separation (MS) impaired development of the
brain and behavior and led to anxiety behavior in the adulthood [35, 36,
37]. MS led to neurochemical, neurohormonal and neurostructural
changes in the brain [38, 39]. Given the above changes in the brains of
MS mice, it is somewhat predictable that MS mice will have a better
response to factors affecting neurological and psychological disorders
than normal (intact) mice.
In this study, exposure of mice to maternal separation stress was
associated with a significant decrease in the time spent in the center of
open field in comparison with the control group. The open field is an
experiment used to measure the amount of locomotor activity and anx-
iety in animals (usually rodents) [40]. Indicator of anxiety-like effects is
decrease in time spent in the central zone of the open field [41]. A 2018
study by Jane et al. Showed that exposure to maternal separation stress
was associated with anxiety-like behavior in the open field test, which
was associated with reduced time spent in the central zone of open field
[42], which is consistent with the results of the present study.
Elevated plus maze (EPM) is a standardized test for evaluating
anxiety-like behavior in laboratory animals. This test is commonly used
to evaluate the anti-anxiety effects of pharmaceutical compounds [43].
This test is based on the animal's propensity for open arms. In the EPM,
anxiety-like behavior is manifested by decreasing in the entries fre-
quency and duration of time spent in the open arms [44]. Studies have
shown that experiencing stressful conditions is associated with
anxiety-related behaviors in the EPM test [42, 45], which is in line with
our results.
Previous studies have introduced various pharmacological properties
for CA including antitumor [18], analgesic [19], anti-Alzheimer's [20],
and anti-inflammatory effects [21]. It has been shown that CA has neu-
roprotective effect in experimental neurological disorders [22]. In the
present study, administration of CA to MS mice increased the time spent
in the central zone of OFT as well as increased the time spent and the
number of entries to the open arms of the EPM. It has been determined
that CA exerted antidepressant- and anxiolytic-like effects in rodents
[23]. In this regard, Takeda et al. demonstrated the antidepressant-like
effect of CA in the forced swimming test in mice. They concluded that
the anti-depressant-like effect of CA was partially mediated by neuro-
genesis and its neuroprotective properties [46]. In another study, Takeda
et al. (2002) showed that CA dose dependently exerted
antidepressant-like activity in stress-exposed mice [47].
Glutamate is an amino acid and an excitatory neurotransmitter in the
brain. Studies have shown that glutamate plays an important role in the
pathophysiology of anxiety [48]. In this regards, previous studies have
showed that activation of NMDA receptors led to anxiety-like behaviors
in mice [12]. Recent studies with genetically modified mice have shown
that deletion of NMDA receptor NR1 subunits, especially from the hip-
pocampal reduced the anxiety-like behavior. These findings indicate that
NMDA receptors in the hippocampus have key role in the development of
anxiety-related behaviors [12]. In line with previous studies, the
expression of NR2a and NR2b subunits of NMDA receptors in the hip-
pocampus of MS mice significantly increased. Our results showed that
treatment of MS mice with CA significantly reduced the expression of the
NR2b subunit of NMDA receptor. This finding indicates that the
anxiolytic-like effect of CA mediated via reduction in the expression of
NMDA receptor in the hippocampus.
In the present study, administration of NMDA significantly reduced
the time spent in the central zone of the OFT and the entries frequency
and spent time in the open arms of EPM indicating activation of NMDA
receptors causes anxiety-like behavior. Salunke et al., showed that NMDA
agonist aggravated anxiety-like behaviors and NMDA antagonist
possessed anxiolytic-like behaviors in mice [49]. Solati et al. showed that
intracerebroventricular injection of different doses of NMDA agonist
Z. Lorigooini et al. Heliyon xxx (xxxx) xxxdecreased the percentage of entries and time spent in open arms of EMP
[50]. In this regards, Engin et al. showed that ketamine has anxiolytic-
and antidepressant-like properties in animal models [51].
In the present study, we observed that MS mice received CA plus
NMDA showed decrease in spent time and entries frequency to the open
arms of EPM and time spent in the central zone of OFT indicating that the
anxiolytic-like effects of CA partially mediated via NMDA receptors.
Furthermore, we co-administrated the sub-effective dose of CA plus ke-
tamine (a NMDA receptor antagonist), we found that entries frequency
and time spent in the open arms of EPM as well as time spent in the
central zone of OFT. These findings confirmed that anxiolytic-like effect
of CA in MS mice partially mediated NMDA receptors. However, future
studies warranted to explore more possible mechanisms are involved in
the anxiolytic-like effect of CA.
5. Conclusion
In conclusion we found that CA exerted anxiolytic-like effect in EPM
and OFT in maternally separated mice. Results showed that co-
administration of NMDA mitigated the beneficial effect of CA and co-
injection of ketamine potentiated the anxiolytic-like effect of CA. Our
findings indicated that NMDA receptors, partially at least, mediated the
anxiolytic-like activity of CA in mouse model of MS induced anxiety-like
behavior.
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